Skip to content

Abbott ESA Chagas Assay Post-Market Study

Abbott ESA Chagas Assay Post-Market Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01662362
Acronym
ESA
Enrollment
63
Registered
2012-08-10
Start date
2012-07-31
Completion date
2012-12-31
Last updated
2014-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chagas Disease

Keywords

Chagas Disease, Trypanosoma cruzi, American trypanosomiasis, South American trypanosomiasis, kissing bugs, reduviid bugs

Brief summary

The study is conducted to meet an FDA post market commitment to collect and report data on the performance of the ESA Chagas assay. A minimum of 50 donor specimens that are FDA-licensed ABBOTT PRISM Chagas repeatedly reactive (RR)will be tested with the ABBOTT ESA Chagas assay. In addition, minimum of 300 ABBOTT PRISM Chagas nonreactive (NR) unidentified donor specimens will be tested with ABBOTT ESA Chagas assay.

Detailed description

ABBOTT ESA Chagas testing will be performed at a minimum of two blood donor centers. Testing will be performed using the FDA-licensed ESA Chagas assay and will be performed in accordance with the ESA Chagas package insert. ABBOTT PRISM Chagas repeatedly reactive blood donor specimens identified by U.S. blood donor centers, as part of the routine blood donation process, will be tested with the FDA-licensed ESA Chagas. Specimens will also be tested with radioimmune precipitation assay (RIPA) for antibody to T. cruzi, a laboratory developed test, and the FDA-licensed ORTHO T. cruzi ELISA. The donor centers will contact the donors and request the donor to return to complete a questionnaire and provide a follow-up specimen. In addition, a minimum of 300 blood donor specimens with ABBOTT PRISM Chagas nonreactive results will also be tested with ESA Chagas. These specimens will be unidentified, leftover specimens from routine donor testing and not individually identifiable. Specimens that are positive or indeterminate with ESA Chagas will be further tested with RIPA.

Interventions

DEVICETesting Donor Specimens with ESA Chagas

Donors will be asked to return for a follow-up blood draw.

Sponsors

Abbott Diagnostics Division
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
17 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

PRISM Chagas Repeatedly Reactive Donor Specimens Inclusion Criteria: * Blood donor specimen documented as PRISM Chagas repeatedly reactive

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
ESA Chagas Testing of US Blood Donor Specimens Repeatedly Reactive by ABBOTT PRISM ChagasUp to six months

Secondary

MeasureTime frame
ESA Testing of Preselected Donor Specimens Nonreactive by ABBOTT PRISM ChagasUp to six months

Countries

United States

Participant flow

Participants by arm

ArmCount
Testing Donor Specimens With ESA Chagas
Test blood donor specimens that are ABBOTT PRISM Chagas Repeatedly Reactive with ESA Chagas. Donors will be asked to return for a follow-up blood draw. Testing Donor Specimens with ESA Chagas: Donors will be asked to return for a follow-up blood draw.
63
Total63

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up38

Baseline characteristics

CharacteristicTesting Donor Specimens With ESA Chagas
Age, Customized
>= 18 years
19 participants
Age, Customized
Unknown
44 participants
Region of Enrollment
United States
63 participants
Sex/Gender, Customized
Female
10 participants
Sex/Gender, Customized
Male
9 participants
Sex/Gender, Customized
Unknown
44 participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 63
serious
Total, serious adverse events
0 / 63

Outcome results

Primary

ESA Chagas Testing of US Blood Donor Specimens Repeatedly Reactive by ABBOTT PRISM Chagas

Time frame: Up to six months

ArmMeasureValue (NUMBER)
Testing Donor Specimens With ESA ChagasESA Chagas Testing of US Blood Donor Specimens Repeatedly Reactive by ABBOTT PRISM Chagas92.06 percent agreement to RIPA
Secondary

ESA Testing of Preselected Donor Specimens Nonreactive by ABBOTT PRISM Chagas

Time frame: Up to six months

ArmMeasureValue (NUMBER)
Testing Donor Specimens With ESA ChagasESA Testing of Preselected Donor Specimens Nonreactive by ABBOTT PRISM Chagas99.00 percentage of specimens ESA negative

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026